Chromocell Therapeutics Corp (CHRO)
US Market

Chromocell Therapeutics Corp (CHRO) Stock Price & Analysis


CHRO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.90 - $6.00
Previous Close$1.97
Average Volume (3M)36.74K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$22.79K
Total Debt (Recent Filing)$631.01K
Price to Earnings (P/E)-2.8
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding5,767,525
10 Day Avg. Volume37,578
30 Day Avg. Volume36,745
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)-2.10
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-12.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Options Prices

Currently, No data available

Ownership Overview

0.00% Other Institutional Investors
90.47% Public Companies and
Individual Investors


What was Chromocell Therapeutics Corp’s price range in the past 12 months?
Chromocell Therapeutics Corp lowest stock price was $1.90 and its highest was $6.00 in the past 12 months.
    What is Chromocell Therapeutics Corp’s market cap?
    Currently, no data Available
    When is Chromocell Therapeutics Corp’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Chromocell Therapeutics Corp’s earnings last quarter?
    Currently, no data Available
    Is Chromocell Therapeutics Corp overvalued?
    According to Wall Street analysts Chromocell Therapeutics Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Chromocell Therapeutics Corp pay dividends?
      Chromocell Therapeutics Corp does not currently pay dividends.
      What is Chromocell Therapeutics Corp’s EPS estimate?
      Chromocell Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Chromocell Therapeutics Corp have?
      Chromocell Therapeutics Corp has 5,767,525 shares outstanding.
        What happened to Chromocell Therapeutics Corp’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Chromocell Therapeutics Corp?
        Currently, no hedge funds are holding shares in CHRO

        Company Description

        Chromocell Therapeutics Corp

        Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
        Popular Stocks
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis